Stathmin-2 Protein

Stathmin-2 Protein (STMN2 / SCG10)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Stathmin-2 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>STMN2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Stathmin-2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=STMN2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neuropathy" style="color:#ef9a9a">Neuropathy</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">42 edges</a></td>
</tr>
</table>

Introduction

Stathmin 2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

...

Stathmin-2 Protein (STMN2 / SCG10)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Stathmin-2 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>STMN2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Stathmin-2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=STMN2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neuropathy" style="color:#ef9a9a">Neuropathy</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">42 edges</a></td>
</tr>
</table>

Introduction

Stathmin 2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Stathmin-2 (STMN2), also known as SCG10 (Superior Cervical Ganglion 10), is a neuron-specific microtubule-destabilizing phosphoprotein belonging to the stathmin family. It plays critical roles in axonal growth, neuronal plasticity, and regeneration. STMN2 is particularly important in the context of neurodegenerative diseases, especially amyotrophic lateral sclerosis (ALS) and peripheral neuropathies^[1].

Structure

Stathmin-2 possesses a distinctive structural organization:

• N-terminal regulatory domain: Contains multiple serine phosphorylation sites (Ser16, Ser25, Ser38, Ser63) that control its microtubule-destabilizing activity. Kinases including [CDK5](/proteins/cdk5), MAPK, and PKA phosphorylate these sites in response to neuronal signals^[2].
• Stathmin-like domain (SLD): The C-terminal region binds directly to α/β-tubulin heterodimers, preventing microtubule polymerization. This domain is highly conserved across the stathmin family.
• C-terminal tail: Mediates protein-protein interactions and subcellular localization.

The protein forms a homodimer and can simultaneously bind two tubulin heterodimers, making it an extremely potent microtubule-destabilizing agent^[3].

Normal Function

Microtubule Regulation

STMN2 is a potent microtubule-destabilizing protein that regulates axonal microtubule dynamics:

Tubulin binding: The stathmin-like domain binds to α/β-tubulin heterodimers with high affinity (Kd ~ 0.1 μM), sequestering them from incorporating into microtubules^[4].

Microtubule catastrophe promotion: Promotes microtubule depolymerization by increasing the frequency of catastrophe events.

Phosphorylation regulation: Phosphorylation at multiple sites by neuronal kinases (CDK5, MAPK, PKA) inhibits tubulin binding, allowing microtubule stabilization during synaptic plasticity^[5].

Neuronal Functions

• Axonal growth during development: High STMN2 expression promotes axonal extension by creating a permissive microtubule environment in growth cones.
• Neuronal plasticity: Regulates microtubule dynamics in [dendritic spines](/mechanisms/dendritic-spines) and presynaptic terminals, affecting synaptic plasticity.
• Nerve injury response: Dramatically upregulated after peripheral nerve injury, promoting axonal regeneration^[6].
• Signal transduction: Acts as a downstream effector of multiple neuronal signaling pathways.

Expression Pattern

Stathmin-2 shows neuron-specific expression:

• Developing nervous system: High expression during embryonic and postnatal development
• Adult brain: Moderate expression in cortical [neurons](/entities/neurons), hippocampal pyramidal cells, and motor neurons
• Peripheral nervous system: High expression in sympathetic neurons and sensory ganglia

Role in Disease

Amyotrophic Lateral Sclerosis (ALS)

STMN2 is dramatically downregulated in ALS patient spinal cord and motor [cortex](/brain-regions/cortex)^[7]:

• Loss of STMN2 correlates with axonal degeneration in motor neurons
• Decreased microtubule dynamics impairs axonal transport
• May contribute to spread of pathology through dying-back neuropathy
• Potential biomarker for disease progression

Charcot-Marie-Tooth Disease (CMT)

• Altered microtubule dynamics due to STMN2 dysregulation contributes to peripheral neuropathy
• May affect axonal regeneration capacity

Spinal Cord Injury

• STMN2 upregulation promotes axonal regeneration after injury
• Therapeutic target for promoting neural repair

Alzheimer's Disease

• Altered stathmin family member expression affects microtubule stability
• May contribute to [tau](/proteins/tau) pathology interactions

Therapeutic Implications

Current Approaches

• Microtubule-stabilizing drugs: Small molecules (epothilones, taxanes) being explored to compensate for STMN2 loss
• Gene therapy: AAV-mediated STMN2 delivery to promote regeneration (preclinical)
• Phosphorylation modulators: Targeting kinases that regulate STMN2 activity

Research Directions

• Understanding STMN2 transcriptional downregulation mechanisms in ALS
• Developing AAV vectors for safe motor neuron delivery
• Biomarker development using STMN2 levels in CSF

Cross-links

• [STMN2 Gene](/genes/stmn2)
• [Axonal Transport](/mechanisms/axonal-transport)
• [Microtubules](/entities/microtubules)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [Neurodegeneration](/diseases/neurodegeneration)

Background

The study of Stathmin 2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• STMN2 Gene
• [Axonal Transport Defects](/mechanisms/axonal-transport-defects)
• [Microtubules](/entities/microtubules)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [Motor Neuron Disease](/diseases/motor-neuron-disease)

External Links

• [UniProt: STMN2](https://www.uniprot.org/uniprot/P17516)
• [PubMed: STMN2](https://pubmed.ncbi.nlm.nih.gov/?term=STMN2+stathmin+neurodegeneration)
• [Allen Brain Atlas: STMN2](https://human.brain-map.org/)

References

[Unknown, Stathmin-2 in neurodegeneration: from physiology to therapy (Trends in Neurosciences, 2018) (2018)](https://doi.org/10.1016/j.tins.2018.05.006)

[Unknown, Phosphorylation of stathmin by neuronal kinases (Journal of Biological Chemistry, 2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/12639951/)

[Unknown, Structure and function of the stathmin family (Nature Reviews Molecular Cell Biology, 2004) (2004)](https://doi.org/10.1038/nrm1347)

[Unknown, Stathmin-tubulin interaction: molecular basis (EMBO Journal, 1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/10545105/)

[Unknown, Neuronal plasticity and stathmin regulation (Neuron, 2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12074649/)

[Unknown, STMN2 upregulation after nerve injury (Journal of Neuroscience, 2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/14749443/)

[Unknown, STMN2 loss in ALS motor neurons (Brain, 2018) (2018)](https://doi.org/10.1093/brain/awy004)